Intervention

For each enrolled patient, the sample described below will be collected as specific intervention intended for research purposes:

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting1

Common conditions10

Lead sponsors shown1

Clinical trials

1 shown

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic CancersNCT06967961 · 2025-07-23

RECRUITING

Common conditions

Adenocarcinoma of Endometrium1 Cervical Carcinoma1 Cutaneous Melanoma1 Nonseminomatous Germ Cell Tumor1 Prostate Adenocarcinoma1 Renal Cancer1 Seminomatous Germ Cell Tumor1 Soft Tissue Sarcoma (STS)1 Upper Aerodigestive Tract Carcinoma1 Urothelial Carcinoma1

Leading sponsors

Institut Claudius Regaud1

Trial status mix

RECRUITING1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.